Analysis of immunoglobulin-like transcripts (ILTs) in lymphocytes with sHLA-G and IL10 from SLE patients

Clinical and Experimental Medicine

Volumn 13, Issue 2, 2013, Pages 135-142

  Chen, Jiaxi ^a   Shen, Bo ^a   Jiang, Yufei ^a   Jun, Li ^a   Zhu, Ming ^a   Chen, Baoguo ^a   Liu, Chibo ^b  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^b TAIZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

IL10; ILT2; sHLA G; SLE

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; HLA G ANTIGEN; IMMUNOGLOBULIN G LIKE TRANSCRIPT 4; IMMUNOGLOBULIN LIKE TRANSCRIPT 2; INTERLEUKIN 10; LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOSURVEILLANCE; LYMPHOCYTE; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HLA-G ANTIGENS; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE COUNT; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; STEROIDS; T-LYMPHOCYTES;

EID: 84877762726     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-012-0185-6     Document Type: Article

References (30)

1. Mok CC, Lau CS (2003) Pathogenesis of systemic lupus erythematosus[J]. J Clin Pathol 56(7):481-490
2. Renaudineau Y, Pers JO, Bendaoud B et al (2004) Dysfunctional B cells in systemic lupus erythematosus[J]. Autoimmun Rev 3(7-8):516-523
3. Brown D, Trowsdale J, Allen R (2004) The LILR family: modulators of innate and adaptive immune pathways in health and disease[J]. Tissue Antigens 64(3):215-225
4. Sayós J, Martínez-Barriocanal A, Kitzig F et al (2004) Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j[J]. Biochem Biophys Res Commun 324(2):640-647
5. Colonna M, Navarro F, Bellon T et al (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells[J]. J Exp Med 186(11):1809-1818
6. Saverino D, Merlo A, Bruno S, et al (2002) Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen- stimulated human T cells[J]. J Immunol 168(1):207-215
7. Navarro F, Llano M, Bellon T, et al (1999) The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells[J]. Eur J Immunol 29(1):277-283
8. Colonna M, Nakajima H, Navarro F et al (1999) A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells[J]. J Leukoc Biol 66(3):375-381
9. Gregori S, Tomasoni D, Pacciani V, et al (2010) Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood[J] 116(6):935-944
10. Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum 25:1271-1277
11. Le Gal FA, Riteau B, Sedlik C et al (1999) HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes[J]. Int Immunol 11(8):1351-1356
12. Pazmany L, Mandelboim O, Valeś-Gómez M et al (1996) Protection from natural killer cell-mediated lysis by HLA-G expression on target cells [J]. Science 274(5288):792-795
13. Contini P,Ghio M,Poggi A et al (2003) SolubleHLA-A;-B;-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation [J]. Eur J Immunol 33:125-134
14. Fournel S, Aguerre-Girr M, Huc X et al (2000) Cutting edge, soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8 [J]. J Immunol 164(12):6100-6104
15. Bainbridge DR, Ellis SA, Sargent IL (2000) HLA-G suppresses proliferation of CD4(+) T-lymphocytes [J]. J Reprod Immunol 48(1):17-26
16. Lila N, Rouas-Freiss N, Dausset J et al (2001) Soluble HLA-G protein secreted by allospecific CD4+ T cells suppresses the alloproliferative response, a CD4+ T cell regulatory mechanism [J]. Proc Natl Acad Sci USA 98(21):12150-12155
17. Gregori S, Magnani CF, Roncarolo MG (2009) Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells [J]. Hum Immunol 70(12):966-969
18. Liang S, Horuzsko A (2003) Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. Hum Immunol 64(11):1025-1032
19. Monsiváis-Urenda A, Niño-Moreno P, Abud Mendoza C et al (2007) Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus(SLE). J Autoimmun 29 (2-3):97-105
20. Kalmbach Y, Boldt AB, Fendel R et al (2006) Increase in annexin V-positive B cells expressing LILRB1/ILT2/CD85j in malaria. Eur Cytokine Netw 17(3):175-180
21. Kuroki K, Tsuchiya N, Shiroishi M et al (2005) Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis[J]. Hum Mol Genet 14(16):2469-2480
22. LeMaoult J, Zafaranloo K, Le Danff C et al (2005) HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 19(6):662-664
23. Urosevic M, Dummer R (2003) HLA-G and IL-10 expression in human cancer: different stories with the same message. Semin Cancer Biol 13(5):337-342
24. Boulland ML, Meignin V, Leroy-Viard K et al (1998) Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas. Am J Pathol 153:1229-1237
25. Urosevic M, Willers J, Mueller B et al (2002) HLA-G protein up-regulation in primary cutaneous lymphomas is associated with IL-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 99:609-617
26. Beinhauer BG, McBride JM, Graf P et al (2004) Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro. Eur J Immunol 34:74-80
27. Rosado S, Perez-Chacon G, Mellor-Pita S et al (2008) Expression of human leukocyte antigen-G in systemic lupus erythematosus. Hum Immunol 69(1):9-15
28. Rizzo R, Hviid TV, Govoni M et al (2008) HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 71(6):520-529
29. Rudstein-Svetlicky N, Loewenthal R, Horejsi V et al (2007) HLA-G levels in serum and plasma. Tissue Antigens 69(1):140-142
30. Rudstein-Svetlicky N, Loewenthal R, Horejsi V et al (2006) HLA-G levels in serum and plasma. Tissue Antigens 67(2):111-116